USA Policy Document

Drug Products, Including Biological Products, that Contain Nanomaterials; Guidance for Industry

2022
Policy Type Regulation
Coverage Level National
Policy Sector Medicine Others

PUBLISHER (s)

  • Food and Drug Administration